The results showed that both subunits of IL-23 were significantly higher expressed in tumor area than that in non-tumor counterparts (for p19, P = 0.035; for p40, P = 0.027, paired-samples T test) (Fig. 1A) in 28 HCC with metastasis. This evidence concerns the gene IL37 and hepatocellular carcinoma.